Sei Investments CO Novavax Inc Transaction History

Sei Investments CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $546,086 - $1.13 Million	-15,052 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$69.73 - $142.9 $497,453 - $1.02 Million	-7,134 Reduced 32.16%	15,052 $1.11 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $1.14 Million - $1.85 Million	-8,502 Reduced 27.7%	22,186 $3.12 Million
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $2.08 Million - $3.17 Million	11,711 Added 61.71%	30,688 $6.35 Million
Q2 2021 Aug 06, 2021	SELL	$121.0 - $257.67 $469,964 - $1 Million	-3,884 Reduced 16.99%	18,977 $4.02 Million
Q1 2021 May 12, 2021	BUY	$112.98 - $319.93 $2.36 Million - $6.69 Million	20,918 Added 1076.58%	22,861 $4.15 Million
Q4 2020 Feb 08, 2021	SELL	$78.74 - $139.5 $127,086 - $225,153	-1,614 Reduced 45.38%	1,943 $217,000
Q3 2020 Nov 06, 2020	SELL	$79.44 - $178.51 $684,455 - $1.54 Million	-8,616 Reduced 70.78%	3,557 $385,000
Q2 2020 Aug 17, 2020	BUY	$13.86 - $83.61 $29,175 - $175,999	2,105 Added 20.91%	12,173 $1.01 Million
Q2 2020 Aug 11, 2020	BUY	$13.86 - $83.61 $139,542 - $841,785	10,068 New	10,068 $839,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $629M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.